Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias

By Gojo Ivana   Sadowska Mariola   Walker Alison   Feldman Eric   Iyer Swaminathan   Baer Maria   Sausville Edward   Lapidus Rena   Zhang Da   Zhu Yali   Jou Ying-Ming   Poon Jennifer   Small Karen   Bannerji Rajat  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 897-908

Springer Publishing Company

Access to resources Recommend Favorite

X-Ray Crystallographic Studies of CDK2, a Basis for Cyclin-Dependent Kinase Inhibitor Design in Anti-Cancer Drug Research

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 1, 2003-01 ,pp. : 15-23

Bentham Science Publishers

Access to resources Recommend Favorite

Pion and Heavy Ion Radiotherapy: Pre-Clinical and Clinical Studies

By Fowler J.F.  

International Journal of Radiation Biology, Vol. 44, Iss. 5, 1983-11 ,pp. : 534-534

Informa Healthcare

Access to resources Recommend Favorite

Targeted Toxins for Glioblastoma Multiforme: Pre-Clinical Studies and Clinical Implementation

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 8, 2011-10 ,pp. : 729-738

Bentham Science Publishers

Access to resources Recommend Favorite

A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol

By Dickson Mark   Shah Manish   Rathkopf Dana   Tse Archie   Carvajal Richard   Wu Nian   Lefkowitz Robert   Gonen Mithat   Cane Lauren   Dials Heather   Schwartz Gary  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1113-1121

Springer Publishing Company

Access to resources Recommend Favorite